Fundraising Fox

Christopher Meldrum

Investor

Not stated at DCVC Bio

Durham, North Carolina, United States

About

Chris Meldrum works on new company creation at DCVC Bio, partnering with scientific founding teams from academia and industry to launch ventures, with a focus on therapeutic platform companies in biotechnology. He previously co-founded and served as Managing Director at Golden Pine Ventures, where he launched and ran six biotech start-ups spun out of eastern U.S. universities, and earlier was Director of Corporate Alliances at Paradigm Genetics and managed biotechnology out-licensing at Purdue University. He holds an MBA from the Carlson School of Management at the University of Minnesota and a bachelor's degree in chemistry from the University of Utah.

Invests in

Biotech

Experience

  1. Avicenna Biosciences, Inc.President & CEOcurrent2020 β€” present
  2. DCVC BioEntrepreneur In Residencecurrent2019 β€” presentRaleigh-Durham-Chapel Hill Area
  3. Alterna Therapeutics, Inc.President & CEO2016 β€” 2021
  4. Pique Therapeutics, Inc.President2005 β€” 2020
  5. Golden Pine VenturesManaging Director2004 β€” 2019
  6. Paradigm GeneticsDirector, Corporate Alliances2001 β€” 2004
  7. Paradigm GeneticsManager, Partnering & Business Strategy2000 β€” 2001
  8. Purdue UniversityLicensing Associate, Office of Technology Commercialization1998 β€” 2000
  9. University of MinnesotaMarketing Associate, Department of Patents & Technology1996 β€” 1998
  10. BioAnalytic MicroSystems, Inc.Director of Business Development (Internship)1997
  11. DataChem LaboratoriesChemistry Technician1993 β€” 1996

Education

  1. UMN Carlson School of ManagementMBA, Finance1996 β€” 1998
  2. University of UtahBachelor of Arts, Chemistry w/ Biochemistry Emphasis1991 β€” 1996
  3. Luiss Guido Carli University1995
  4. Highland High School1987 β€” 1991

Skills & more

Biotechnology62Venture Capital67Licensing33Start-ups81Entrepreneurship44Financial Analysis5Executive Management6Patents10Mergers3Pharmaceutical Industry26Lifesciences23Angel Investing8
+12 moreMergers & AcquisitionsTechnology TransferDue DiligencePrivate PlacementsAcquisitionsCrossFitImmunologyClinical TrialsDrug DevelopmentNegotiationCompetitive IntelligenceBusiness Strategy

Languages English Β· French Β· Italian

From Christopher's professional profile.

Same school

Shared employers

Colleagues at DCVC Bio